Global Drug Facility offers PASER without the need for cold chain storage

Stop TB Partnership
June 13, 2014, 3:25 p.m.

10 June, 2014 - Geneva - GDF supplier Jacobus can now offer PASER that has been permitted storage below +25°C with a shelf life of 24 months. Based on recently submitted stability data - information proving the stability of the product under room temperature conditions - it was accepted by GDF/GFATM.

Earlier PASER had to be kept under +15C degrees, requiring cold chain maintenance. Now this programmatic barrier has been released. This product can now be stored between below +25C.

PASER is used to treat drug resistant TB. All countries that had used PASER before, but encountered the storage complications, will now be benefiting from this change, in addition to any other country willing to obtain this product through GDF.

There is no requirement for cold chain storage of this product any longer. The new artwork will be updated as per the GDF requirements and will reflect the new change in storage requirements.


Source: Stop TB Partnership